1. Home
  2. SNEX vs BIO Comparison

SNEX vs BIO Comparison

Compare SNEX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo StoneX Group Inc.

SNEX

StoneX Group Inc.

HOLD

Current Price

$68.45

Market Cap

9.1B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$383.03

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNEX
BIO
Founded
1924
1952
Country
United States
United States
Employees
5400
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.0B
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
SNEX
BIO
Price
$68.45
$383.03
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$81.33
$339.75
AVG Volume (30 Days)
966.9K
275.3K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
142.61
EPS
3.49
N/A
Revenue
$132,378,200,000.00
$2,583,200,000.00
Revenue This Year
N/A
$2.74
Revenue Next Year
$4.17
$3.20
P/E Ratio
$19.41
N/A
Revenue Growth
32.53
0.65
52 Week Low
$63.33
$236.73
52 Week High
$141.99
$385.92

Technical Indicators

Market Signals
Indicator
SNEX
BIO
Relative Strength Index (RSI) 37.50 78.90
Support Level $63.33 $289.16
Resistance Level $79.35 N/A
Average True Range (ATR) 2.70 10.41
MACD 1.77 1.72
Stochastic Oscillator 69.49 95.01

Price Performance

Historical Comparison
SNEX
BIO

About SNEX StoneX Group Inc.

StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: